What are the industrial and design requirements for clean clothing?



The clean clothes have two performances of dust-free and anti-static. The high-quality polyester filament fabric is selected, and it has the characteristics of dust-free, filterability, comfort, durability, high temperature resistance and cleaning resistance. It adopts imported high-quality The conductive wire ensures the excellent anti-static performance of the product.
Clean clothing process and design requirements:
1. The overlocking process is used in the sewing process of clean clothes to avoid fiber exposure and shedding, and at the same time improve the firmness and tensile properties of the seamed parts of the clothing.
2. Elastic cuffs or double-layer cuffs are used for the cuffs and trousers of the clean clothes, which can effectively prevent dust and dander from the human body from falling into the food, thereby affecting the quality of the product.
3. The clean clothes are sealed with zippers instead of buttons. The buttons are easy to fall off, and the sealing performance is poor. The dust carried by the human body will be emitted from the clothes to the production workshop, affecting the cleanliness of the production environment.
The role of clean clothes: In order to prevent the dander from falling off the human body and causing drug pollution, etc., production personnel are required to wear clean clothes with dust-proof, anti-bacteria and anti-static properties in the clean room. High-quality clean clothes can improve the cleanliness of the clean area. Thereby improving the quality of pharmaceuticals.
Design requirements for clean clothes: When designing clean clothes, first of all, it must have the five basic elements of clean clothes in pharmaceutical factories: clean performance, electrostatic performance, comfort, and durability. place, and minimize the places where clothing can accumulate dust. Only high standard clean clothes can highlight the high quality of clean clothes. So as to provide a better guarantee for the quality of our pharmaceutical products.

